Related Experiment Video

Updated: Aug 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

SnoN is a cell type-specific mediator of transforming growth factor-beta responses

Krishna P Sarker1, Sylvia M Wilson, Shirin Bonni

  • 1Cancer Biology Research Group and Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.

The Journal of Biological Chemistry
|January 29, 2005
PubMed

Insights

Endogenous SnoN protein positively mediates transforming growth factor-beta (TGF-beta) signaling, promoting gene transcription and cell cycle arrest in lung epithelial cells, contrary to previous suppression hypotheses.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial for development and homeostasis, involving Smad proteins for intracellular signal propagation.
  • The nuclear protein SnoN was previously suggested to suppress TGF-beta-induced Smad signaling and cell proliferation inhibition.
  • The physiological role of endogenous SnoN in TGF-beta-mediated cellular responses was not fully understood.

Purpose of the Study:

  • To investigate the function of endogenous SnoN in TGF-beta-mediated responses using genetic knockdown.
  • To determine if SnoN acts as a suppressor or mediator of TGF-beta signaling in mammalian cells.

Main Methods:

  • Utilized RNA interference (RNAi) to genetically knock down SnoN expression in mammalian cell lines (Mv1Lu, HeLa, HaCaT).
  • Assessed the impact of SnoN knockdown on TGF-beta-induced gene transcription and cell cycle arrest.

Main Results:

  • SnoN knockdown specifically inhibited TGF-beta-induced transcription in Mv1Lu lung epithelial cells, but not in HeLa or HaCaT cells.
  • Knockdown of SnoN blocked TGF-beta-dependent cell cycle arrest in Mv1Lu cells.
  • These findings indicate SnoN's role as a positive mediator in a cell-specific manner.

Conclusions:

  • Endogenous SnoN functions as a positive mediator of TGF-beta-induced transcription and cell cycle arrest in lung epithelial cells.
  • SnoN's role in TGF-beta signaling is cell-specific, coupling TGF-beta signals to gene expression.
  • The study redefines SnoN's function from a potential suppressor to a crucial mediator in specific cellular contexts.

More Related Videos

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing07:05

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Published on: February 26, 2021

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.